Equity
AOCI
Vertex Pharmaceuticals AOCI increased by 256.0% to $24.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 63.6%, from $68.10M to $24.80M. Over 5 years (FY 2020 to FY 2025), AOCI shows an upward trend with a -25.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2012
Last reportedQ1 2026May 5, 2026
How to read this metric
Fluctuations often reflect macroeconomic factors like interest rate changes or currency volatility rather than core operational performance.
Detailed definition
Accumulated Other Comprehensive Income represents the cumulative unrealized gains and losses that are excluded from net...
Peer comparison
Varies significantly based on the company's hedging strategy and international exposure.
Metric ID:
aociHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$25.16M | $11.54M | $15.90M | $11.30M | $57.50M | $97.60M | $800.00K | -$13.10M | -$39.80M | -$3.00M | -$14.30M | $17.30M | $22.50M | $28.80M | $127.80M | $68.10M | -$101.10M | -$64.50M | -$15.90M | $24.80M |
| QoQ Change | — | +145.9% | +37.8% | -28.9% | +408.8% | +69.7% | -99.2% | <-999% | -203.8% | +92.5% | -376.7% | +221.0% | +30.1% | +28.0% | +343.8% | -46.7% | -248.5% | +36.2% | +75.3% | +256.0% |
| YoY Change | — | — | — | — | +328.5% | +746.0% | -95.0% | -215.9% | -169.2% | -103.1% | <-999% | +232.1% | +156.5% | >999% | +993.7% | +293.6% | -549.3% | -324.0% | -112.4% | -63.6% |
Range-$101.10M – $127.80M
CAGR-0.3%
Avg YoY Growth+18.2%
Median YoY Growth-79.3%
Current Streak3 quarters growth
AOCI at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's aoci?
- Vertex Pharmaceuticals (VRTX) reported aoci of $24.80M in Q1 2026.
- How has Vertex Pharmaceuticals's aoci changed year-over-year?
- Vertex Pharmaceuticals's aoci decreased by 63.6% year-over-year, from $68.10M to $24.80M.
- What is the long-term trend for Vertex Pharmaceuticals's aoci?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's aoci has grown at a -25.3% compound annual growth rate (CAGR), from -$68.50M to -$15.90M.
- What does aoci mean?
- Cumulative gains or losses not yet recognized in the income statement.